Breaking News

Fujifilm Diosynth Opens New Lab

Construction now complete on new 62,000 square foot facility in North Carolina

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies USA, a biologics contract development and manufacturing organization, with experience focused on the development and manufacture of recombinant biopharmaceuticals including proteins, vaccines, and monoclonal antibodies, completed the construction of a new three-story, 62,000 square-foot state-of-the-art facility in Research Triangle Park, NC. “The construction and completion of this building reflects the continued commitment of our organization to provide our...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters